Evidence map›Paper›PMID 38516744›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Laser-Synthesized Germanium Nanoparticles as Biodegradable Material for Near-Infrared Photoacoustic Imaging and Cancer Phototherapy.

Iaroslav B Belyaev, Ivan V Zelepukin, Polina A Kotelnikova, Gleb V Tikhonowski, Anton A Popov, Alina Yu Kapitannikova, Jugal Barman, Alexey N Kopylov, Daniil N Bratashov, Ekaterina S Prikhozhdenko and 3 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Recent Advancements in Lung Cancer Metastasis Prevention Based on Nanostrategies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. A Porphyrin Nanomaterial for Photoimmunotherapy for Treatment of Melanoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Protein-functionalized and intrinsically radiolabeled [European journal of nuclear medicine and molecular imaging · 2025
    Article
  8. Polyacrylic Acid-Coated LaBPharmaceutics · 2025
    Article
  9. Biodegradable ICG-Conjugated Germanium Nanoparticles forACS applied materials & interfaces · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Iaroslav B BelyaevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, 117997, Russia.
Ivan V ZelepukinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, 117997, Russia.ORCID 0000-0003-0209-2116
Polina A KotelnikovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, 117997, Russia.
Gleb V TikhonowskiNational Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow, 115409, Russia.
Anton A PopovNational Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow, 115409, Russia.
Alina Yu KapitannikovaInstitute of Molecular Theranostics, Sechenov University, Moscow, 119435, Russia.
Jugal BarmanShemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, 117997, Russia.
Alexey N KopylovNational Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow, 115409, Russia.
Daniil N BratashovPhysics Institute, Saratov State University, Saratov, 410012, Russia.
Ekaterina S PrikhozhdenkoPhysics Institute, Saratov State University, Saratov, 410012, Russia.
Andrei V KabashinCNRS, LP3, Campus de Luminy - Case 917, Aix Marseille University, Marseille, Cedex, 13288, France.
Sergey M DeyevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, 117997, Russia.
Andrei V ZvyaginShemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, 117997, Russia.ORCID 0000-0001-8799-2257
Institute of Bioorganic Chemistry · RUNational Research Nuclear University MEPhI · RUSechenov University · RUSaratov State University · RUCentre National de la Recherche Scientifique · FRUppsala University · SE

Funding

Russian Science Foundation 21-74-30016Russian Science Foundation 22-72-00015
6 · The paper itself

Abstract

Biodegradable nanomaterials can significantly improve the safety profile of nanomedicine. Germanium nanoparticles (Ge NPs) with a safe biodegradation pathway are developed as efficient photothermal converters for biomedical applications. Ge NPs synthesized by femtosecond-laser ablation in liquids rapidly dissolve in physiological-like environment through the oxidation mechanism. The biodegradation of Ge nanoparticles is preserved in tumor cells in vitro and in normal tissues in mice with a half-life as short as 3.5 days. Biocompatibility of Ge NPs is confirmed in vivo by hematological, biochemical, and histological analyses. Strong optical absorption of Ge in the near-infrared spectral range enables photothermal treatment of engrafted tumors in vivo, following intravenous injection of Ge NPs. The photothermal therapy results in a 3.9-fold reduction of the EMT6/P adenocarcinoma tumor growth with significant prolongation of the mice survival. Excellent mass-extinction of Ge NPs (7.9 L g

Indexed as

GermaniumPhotoacoustic TechniquesPhototherapyAnimalsBiocompatible MaterialsCell Line, TumorDisease Models, AnimalFemaleLasersMetal NanoparticlesMiceNanoparticlesNeoplasmsBiocompatible MaterialsGermaniumbiodegradable materialsgermaniumlaser ablationphotoacoustic imagingphotothermal therapy

Identifiers

PMID38516744
PMCPMC11132077
OpenAlexW4393089660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.